#herpesvirus — Tuesday, September 01, 2026 (1 items)
| 0 | ℹ |
Efficacy and Safety of Pritelivir vs Foscarnet for the Treatment of Acyclovir-Refractory Herpes Simplex Virus Infection in Immunocompromised Adults: A Randomized, Open-Label Phase 2 Trial.
(academic.oup.com)
|
Open Forum Infectious Diseases 2026-09-01 | #clinical trial #immunocompromised #herpesvirus #antiviral #amr |